Clinical trial
Scand-Ankle: A Gold Standard Programme for Alcohol Cessation Intervention in Patients Undergoing Acute Fracture Surgery - A Randomised Clinical Multi-centre Study
NCT00986791 is registered in ClinicalTrials.gov with Bispebjerg Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Scand-Ankle: A Gold Standard Programme for Alcohol Cessation Intervention in Patients Undergoing Acute Fracture Surgery - A Randomised Clinical Multi-centre Study
- Lead sponsor
- Bispebjerg Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2010
- Completion date
- March 31, 2018
- Enrollment
- 70 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
acute fracture surgery, alcohol cessation intervention, ankle injuries, infection, postoperative complications